UMC Board

UMC has an international board; WHO and the Swedish government each appoint three members and three alternate members.

UMC Board, December 2019

The operations of UMC as a WHO Collaborating Centre are governed by an agreement between WHO Headquarters and the Swedish government. The centre has an international board; WHO and the Swedish government each appoint three members and three alternate members.

Since May 2019, the board has been chaired by Dr Filippa Nyberg, Chief Medical Officer, Karolinska University Hospital, Associate Professor, Karolinska Institutet.

The other members appointed by the Swedish Government are:

Professor Johanna Adami, Principal, Sophiahemmet University

Dr Thomas Bradley, Pharmacovigilance consultant, Stockholm

Alternates:

Professor Gert Ragnarsson

Dr Karin Meyer, CEO, Swedish Pharmaceutical Society

WHO has appointed:

Dr Rogério Gaspar, Director, Regulation and Prequalification, World Health Organization

Dr Gayatri Jayaraman, Marketed Health Products Safety and Effectiveness Information Bureau, Canada

Dr Fred Moin Siyoi, CEO, Pharmacy and Poisons Board, Kenya

Alternates:

Dr Shanthi Pal, Acting Team Lead, Pharmacovigilance, World Health Organization

Dr Jun Kitahara, Director, International Information Group, Risk Communication Promotion Division, Safety, Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Mr Mick Foy, Group Manager, MHRA , Vigilance and Risk Management of Medicines

Last modified on: March 24, 2021
.